Abstract
Patients presenting with cardiogenic shock and severe combined aortic and mitral regurgitation represent a major clinical challenge. Therapeutic options are limited in this setting as they are often deemed inoperable due to prohibitive risk for surgery, while mechanical circulatory support is usually contraindicated or technically challenging. Medical therapy, on the other hand, is associated with high-mortality rates. Therefore, percutaneous therapies may represent an appealing alternative. Here, we present a "one-stop-shop" totally percutaneous approach for severe aortic and mitral regurgitation in a patient with cardiogenic shock.
Keywords:
aortic valve disease; cardiogenic shock; mitral valve disease; percutaneous valve therapy.
© 2019 Wiley Periodicals, Inc.
Publication types
-
Case Reports
-
Video-Audio Media
MeSH terms
-
Aortic Valve / diagnostic imaging
-
Aortic Valve / physiopathology
-
Aortic Valve / surgery*
-
Aortic Valve Insufficiency / diagnostic imaging
-
Aortic Valve Insufficiency / physiopathology
-
Aortic Valve Insufficiency / surgery*
-
Heart Valve Prosthesis
-
Hemodynamics
-
Humans
-
Male
-
Middle Aged
-
Mitral Valve / diagnostic imaging
-
Mitral Valve / physiopathology
-
Mitral Valve / surgery*
-
Mitral Valve Insufficiency / diagnostic imaging
-
Mitral Valve Insufficiency / physiopathology
-
Mitral Valve Insufficiency / surgery*
-
Prosthesis Design
-
Recovery of Function
-
Severity of Illness Index
-
Shock, Cardiogenic / diagnosis
-
Shock, Cardiogenic / physiopathology*
-
Transcatheter Aortic Valve Replacement* / instrumentation
-
Treatment Outcome
-
Ventricular Function, Left